Cassava Sciences reported $0 in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Amgen USD 54.6B 17M Dec/2025
Biogen USD 6.56B 275.1M Mar/2026
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.5B 3.6M Dec/2025
Geron USD 121.99M 76K Dec/2025
J&J USD 47.93B 2.14B Dec/2025
Merck USD 49.34B 7.97B Dec/2025
Novartis USD 47B 11.62B Mar/2026
Novavax USD 233.31M 4.23M Sep/2024
Pfizer USD 63.73B 231M Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025